Abstract

BackgroundOptic nerve injury is an important pathological component in neurodegenerative diseases such as traumatic optic neuropathies and glaucoma. The molecular signaling pathway(s) critical for retinal ganglion cell (RGC) death after axonal insult, however, is/are not fully defined. RGC death after axonal injury is known to occur by BAX-dependent apoptosis. Two transcription factors JUN (the canonical target of JNK) and DDIT3 (CHOP; a key mediator of the endoplasmic reticulum stress response) are known to be important apoptotic signaling molecules after axonal injury, including in RGCs. However, neither Jun nor Ddit3 deficiency provide complete protection to RGCs after injury. Since Jun and Ddit3 are important apoptotic signaling molecules, we sought to determine if their combined deficiency might provide additive protection to RGCs after axonal injury.MethodsTo determine if DDIT3 regulated the expression of JUN after an axonal insult, mice deficient for Ddit3 were examined after optic nerve crush (ONC). In order to critically test the importance of these genes in RGC death after axonal injury, RGC survival was assessed at multiple time-points after ONC (14, 35, 60, and 120 days after injury) in Jun, Ddit3, and combined Jun/Ddit3 deficient mice. Finally, to directly assess the role of JUN and DDIT3 in axonal degeneration, compound actions potentials were recorded from Jun, Ddit3, and Jun/Ddit3 deficient mice after ONC.ResultsSingle and combined deficiency of Jun and Ddit3 did not appear to alter gross retinal morphology. Ddit3 deficiency did not alter expression of JUN after axonal injury. Deletion of both Jun and Ddit3 provided significantly greater long-term protection to RGCs as compared to Jun or Ddit3 deficiency alone. Finally, despite the profound protection to RGC somas provided by the deficiency of Jun plus Ddit3, their combined loss did not lessen axonal degeneration.ConclusionsThese results suggest JUN and DDIT3 are independently regulated pro-death signaling molecules in RGCs and together account for the vast majority of apoptotic signaling in RGCs after axonal injury. Thus, JUN and DDIT3 may represent key molecular hubs that integrate upstream signaling events triggered by axonal injury with downstream transcriptional events that ultimately culminate in RGC apoptosis.

Highlights

  • Optic nerve injury is an important pathological component in neurodegenerative diseases such as traumatic optic neuropathies and glaucoma

  • In retinas with conditional deletion of Jun, JUN accumulation after optic nerve crush (ONC) was detected in approximately 22% of retinal ganglion cell (RGC) after ONC compared to wildtype retinas (Fig. 1D, P

  • Combined deficiency of Jun and Ddit3 is more protective after axonal injury than either Jun or Ddit3 deficiency alone Since our results suggest that Jun and Ddit3 are independently upregulated after optic nerve injury, animals deficient in both Jun and Ddit3 were generated to determine if the protection afforded by the individual deficiencies is additive

Read more

Summary

Introduction

Optic nerve injury is an important pathological component in neurodegenerative diseases such as traumatic optic neuropathies and glaucoma. Two transcription factors JUN (the canonical target of JNK) and DDIT3 (CHOP; a key mediator of the endoplasmic reticulum stress response) are known to be important apoptotic signaling molecules after axonal injury, including in RGCs. neither Jun nor Ddit deficiency provide complete protection to RGCs after injury. MAPK pathway components, including c-Jun Nterminal kinases (JNKs) and their canonical target JUN ( known as cJUN), and ER stress signaling, and its downstream effector DNA damage inducible transcript 3, Ddit ( known as CCAAT/enhancer binding homologous protein (CHOP)/GADD153), are known to be important pro-apoptotic cascades after glaucoma-relevant injuries [21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36]. It must be determined if JUN and DDIT3 act through distinct mechanisms in RGCs and provide additive protection to RGCs after axonal injury

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call